SCHEDULE: Vanguard Group Amends Utah Medical Products Ownership

The Vanguard Group reports 0% beneficial ownership in Utah Medical Products Inc. common stock following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 2 to its Schedule 13G for Utah Medical Products Inc.
• The filing reports that The Vanguard Group's aggregate beneficial ownership of Utah Medical Products Inc. common stock is now 0%.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, procedural filing reflecting an internal organizational change by The Vanguard Group rather than a direct statement on Utah Medical Products Inc.'s performance or prospects.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc.
• These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that such internal realignments by large asset managers like Vanguard are common for operational efficiency or regulatory compliance, leading to disaggregated reporting across their various funds and divisions. This does not necessarily reflect a change in investment thesis for Utah Medical Products Inc. by all Vanguard-managed funds.

Stakeholder Impact

• Minimal direct impact on Utah Medical Products Inc. shareholders, as the underlying investment by Vanguard-affiliated entities may still exist, just reported differently by individual subsidiaries.

Key Dates

Keywords

Schedule 13G, beneficial ownership, Vanguard Group, Utah Medical Products Inc., common stock, internal realignment, SEC filing